# Endomatic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endomatic

- Industry: Medical Devices & Equipment
- Headquarters: Or Yehuda, Israel
- Latest round: Seed (Aug 18, 2025)
- Investors on record: 1

## About

Based in Isreal, and incorporated in 2018, Endomatic is a healthcare equipment manufacturer that develops endovascular Left Atrial Appendage (LAA) closure device to prevent stroke. In August 2025, Endomatic raised an amount of seed funding from returning investor Peregrine Ventures. As of 2026, Boaz Schwarz is leading the firm as CEO.

Endomatic’s core product is a patented, non thrombogenic endovascular LAA closure device. Traditional LAA implants may trigger clot formation when exposed to circulating blood, creating DRT and increasing stroke risk. Endomatic’s technology is designed to eliminate this risk by preventing thrombus formation on the device surface. The product is intended for use during standard LAA occlusion procedures.

## Funding rounds

- Seed, Aug 18, 2025 — Peregrine Ventures
- Seed, Jan 2, 2024 — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Seed